Form 4: Inari Medical Chief Medical Officer Sells 4,000 Shares Under 10b5-1 Plan

Inari Medical's Chief Medical Officer, Thomas Tu, sold 4,000 shares of common stock at $55 per share on December 10, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• Thomas Tu, the Chief Medical Officer of Inari Medical, Inc., sold 4,000 shares of the company's common stock on December 10, 2024.
• The sale was executed at a price of $55 per share.
• This transaction was conducted under a pre-established Rule 10b5-1 trading plan adopted on November 11, 2023.
• Following the transaction, Mr. Tu directly owns 304,036 shares of Inari Medical common stock.

Sentiment

Score: 5

Explanation: The document is a routine SEC filing related to a pre-planned stock sale by an executive. It does not indicate any positive or negative sentiment about the company's performance.

Industry Context

This is a routine filing related to insider trading activity. It is common for executives to use 10b5-1 plans to manage their stock sales and avoid accusations of insider trading.

Comparison to Industry Standards

• The use of 10b5-1 trading plans is a common practice among executives at publicly traded companies, including those in the medical device industry.
• Similar filings are regularly made by executives at companies like Medtronic, Boston Scientific, and Abbott, when they execute pre-planned stock sales.

Stakeholder Impact

• The stock sale by a company executive may have a minor impact on shareholder sentiment, but is unlikely to significantly affect the stock price due to the pre-planned nature of the transaction.

Key Dates

Keywords

Inari Medical, Thomas Tu, Chief Medical Officer, stock sale, Rule 10b5-1, insider trading, NARI